Somerville, NJ, United States of America

Vidyadhar Madhav Paradkar

This inventor holds 28 USPTO granted patents and 1 published patent application, plus 4 CIPO patents and 6 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Dr. Reddy's Laboratories, Incorporated, Pharmacopeia Drug Discovery, Inc., Berlex Laboratories, Inc.. Active years: 2002-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vidyadhar Madhav Paradkar. Retrieved from https://idiyas.com/inventor/vidyadhar-madhav-paradkar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 28 

% Patents Active = 25.0

 

 

Average Co-Inventor Count = 8.4

ph-index = 6

Forward Citations = 138(Granted Patents)


Location History:

  • Sommerville, NJ (US) (2011)
  • Somerville, NJ (US) (2002 - 2014)
  • Branchburg, NJ (US) (2015 - 2019)

Company Filing History:


Years Active: 2002-2019

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Tropomyosin Receptor Kinase
Cyclin Dependent Kinase
NOS Inhibitors
Pyrazolo Compounds
Immunosuppression
Heterocyclic Compounds
Bradykinin Antagonists
Lipoprotein Lipase
28 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Vidyadhar Madhav Paradkar

Introduction

Vidyadhar Madhav Paradkar, based in Somerville, NJ, is a distinguished inventor with an impressive portfolio of 28 patents. His work predominantly focuses on the field of pharmaceutical sciences, where he has made significant advancements that contribute to medical treatments.

Latest Patents

Among his recent innovations are two notable patents for "Substituted pyrazolo[1,5-a] pyridine as tropomyosin receptor kinase (Trk) inhibitors." These patents describe a series of substituted pyrazolo[1,5-a]pyridine compounds, detailing their potential use as inhibitors of the tropomyosin receptor kinase (Trk) family protein kinases. The applications also outline methods of synthesizing these compounds alongside pharmaceutical compositions that incorporate them, indicating significant promise in therapeutic areas.

Career Highlights

Vidyadhar has made substantial contributions while working at prominent companies such as Pharmacopeia Drug Discovery, Inc. and Dr. Reddy's Laboratories, Incorporated. His innovative approaches in drug discovery and development have enabled progress in understanding and targeting specific kinases, which are essential in various disease mechanisms.

Collaborations

Throughout his career, Vidyadhar has collaborated with esteemed professionals, including coworkers John J Baldwin and Michael H J Ohlmeyer. Their joint efforts have fostered a collaborative environment that nurtures creativity and enhances research output in their respective fields.

Conclusion

Vidyadhar Madhav Paradkar's contributions through his inventions and patents demonstrate his commitment to advancing pharmaceutical research. His work not only influences current drug development but also holds potential for future innovations that can lead to breakthroughs in medical therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…